Molecular Genetics Laboratory, Genes Disease and Therapy Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.
Department of Physiology.
J Am Soc Nephrol. 2018 Jun;29(6):1624-1635. doi: 10.1681/ASN.2017111205. Epub 2018 Apr 2.
Reabsorption of amino acids (AAs) across the renal proximal tubule is crucial for intracellular and whole organism AA homeostasis. Although the luminal transport step is well understood, with several diseases caused by dysregulation of this process, the basolateral transport step is not understood. In humans, only cationic aminoaciduria due to malfunction of the basolateral transporter yLAT1/CD98hc (SLC7A7/SLC3A2), which mediates the export of cationic AAs, has been described. Thus, the physiologic roles of basolateral transporters of neutral AAs, such as the antiporter LAT2/CD98hc (SLC7A8/SLC3A2), a heterodimer that exports most neutral AAs, and the uniporter TAT1 (SLC16A10), which exports only aromatic AAs, remain unclear. Functional cooperation between TAT1 and LAT2/CD98hc has been suggested by studies but has not been evaluated To study the functional relationship of TAT1 and LAT2/CD98hc , we generated a double-knockout mouse model lacking TAT1 and LAT2, the catalytic subunit of LAT2/CD98hc (dKO LAT2-TAT1 mice). Compared with mice lacking only TAT1 or LAT2, dKO LAT2-TAT1 mice lost larger amounts of aromatic and other neutral AAs in their urine due to a tubular reabsorption defect. Notably, dKO mice also displayed decreased tubular reabsorption of cationic AAs and increased expression of yLAT1/CD98hc. The LAT2/CD98hc and TAT1 transporters functionally cooperate , and yLAT1/CD98hc may compensate for the loss of LAT2/CD98hc and TAT1, functioning as a neutral AA exporter at the expense of some urinary loss of cationic AAs. Cooperative and compensatory mechanisms of AA transporters may explain the lack of basolateral neutral aminoacidurias in humans.
氨基酸(AAs)在肾近端小管的重吸收对于细胞内和整个机体 AAs 的稳态至关重要。尽管对该过程的腔侧转运步骤已有很好的了解,并且有几种疾病是由于该过程的失调引起的,但基底外侧转运步骤尚不清楚。在人类中,仅有阳离子氨基酸尿症是由于基底外侧转运体 yLAT1/CD98hc(SLC7A7/SLC3A2)功能障碍引起的,该转运体介导阳离子 AAs 的输出。因此,中性 AAs 的基底外侧转运体的生理作用,如中性氨基酸的反向转运体 LAT2/CD98hc(SLC7A8/SLC3A2),它可以输出大多数中性氨基酸,以及单转运体 TAT1(SLC16A10),它仅输出芳香族氨基酸,仍然不清楚。功能合作之间的 TAT1 和 LAT2/CD98hc 已被提出 由研究,但尚未进行评估 为了研究 TAT1 和 LAT2/CD98hc 的功能关系,我们生成了一种缺乏 TAT1 和 LAT2 的双敲除鼠模型,LAT2/CD98hc 的催化亚基(dKO LAT2-TAT1 小鼠)。与仅缺乏 TAT1 或 LAT2 的小鼠相比,dKO LAT2-TAT1 小鼠由于肾小管重吸收缺陷,尿液中丢失了更多的芳香族和其他中性氨基酸。值得注意的是,dKO 小鼠还显示出阳离子氨基酸的肾小管重吸收减少和 yLAT1/CD98hc 的表达增加。LAT2/CD98hc 和 TAT1 转运体在功能上合作,yLAT1/CD98hc 可能代偿 LAT2/CD98hc 和 TAT1 的缺失,作为中性 AA 输出体发挥作用,代价是一些阳离子 AA 的尿丢失。AA 转运体的合作和代偿机制可能解释了人类缺乏基底外侧中性氨基酸尿症的原因。